Anne-Cecile Bayne, global science & innovation lead Pharma & Medical Nutrition, DSM discusses the benefits of using antioxidants to block nitrosamine development in drug products, and futureproof pharma formulations.
Datwyler Healthcare's Tabassam Sharif, regulatory affairs manager and Eugene Polini, technical key account manager, explain how parenteral packaging suppliers are optimising their technologies and processes to meet regulatory requirements.
Sally-Anne Whybrow, healthcare business development manager, Siemens Financial Services, UK examines how smart financing can help CROs invest in financially-sustainable technology.
Rebekah Jordan shares her view from the seat at the Editor’s Desk on what impact the post-Brexit era might have on the UK process of medicine approvals and how external pharma manufacturers may respond.
Kry is expanding its chronic disease management and population health solutions with the launch of new treatment pathways for obesity. Through boosting access, Kry hopes to keep patients healthier for longer, reducing the need for medical treatments.
A digestive supplement known as, JUVIA Digestive Balance Formula, has recently been launched to treat people with IBS, powered by plants and backed up by science.
Henk de Wilde, chief operating officer and R&D Director, iQure Pharma discusses how better understanding of pain is helping researchers to develop novel therapeutics as non-opioid alternatives to manage neuropathic pain.
EPM spoke exclusively with Heiko Schmidt, Strategy & Consulting Life Sciences lead, Accenture AG, about why CDMOs should be prepared to track sustainability metrics now and how companies which wait, will likely be forced to catch-up at higher costs.
Dr. Karen Rowland Yeo, senior vice president, Client & Regulatory Strategy, Certara UK, describes how pioneering biosimulation is helping to predict drug exposures during pregnancy, providing opportunities for safer care and better outcomes.
Rebekah Jordan fired out some quick Q&As with the Verseon team to shed light on their PKI treatment for diabetic vision loss, its advantages over injection treatments as well as its effectiveness long term.
Cihan Likogullari, head of EMEA at Envirotainer, explores how calculating Total Landed Cost can help pharma companies make more informed decisions about packaging and the hidden costs that may come alongside it.
Rebekah Jordan sits with Marty Gauvin, CEO of Fertilis, to discuss its IVF treatment innovation that replicates nature and automates the cell culture process, as well as its potential applications in regenerative medicine.
